Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
McKesson
Express Scripts
Federal Trade Commission
US Army
US Department of Justice
Chinese Patent Office
Harvard Business School

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089475

« Back to Dashboard

NDA 089475 describes PROTAMINE SULFATE, which is a drug marketed by Fresenius Kabi Usa, Lilly, Pharmacia And Upjohn, and West-ward Pharms Int, and is included in five NDAs. It is available from one supplier. Additional details are available on the PROTAMINE SULFATE profile page.

The generic ingredient in PROTAMINE SULFATE is protamine sulfate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the protamine sulfate profile page.
Summary for 089475
Tradename:PROTAMINE SULFATE
Applicant:West-ward Pharms Int
Ingredient:protamine sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Nov 5, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Medtronic
US Army
Fuji
AstraZeneca
McKesson
Baxter
QuintilesIMS
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.